Welcome to the Chu Lab

Our studies are focused on studying diagnostics, prevention and treatment strategies against influenza, RSV, SARS-CoV-2 and emerging respiratory viruses. We conduct large-scale community-based studies of respiratory virus transmission, and clinical trials of vaccines and therapeutics. We evaluate immune correlates of protection against respiratory viruses in human cohort studies and describe mechanisms underlying maternal-fetal immunity, particularly for vaccines given during pregnancy to protect the mother, fetus, and infant.

Our current research studies focus on identifying strategies for control of the ongoing SARS-CoV-2 pandemic. We have conducted community-based testing studies in households with young children, and have conducted clinical trials of on-site diagnostics and treatment in homeless shelters, and surveillance studies for SARS-CoV-2 containment on an undergraduate college campus. We have established a longitudinal cohort of SARS-CoV-2 convalescent individuals for studies of long COVID and immune profiling of vaccination and infections, including with novel variants as they emerge.

Our goal is to identify strategies for pandemic preparedness and to develop scalable platforms that can be rapidly deployed for current and future pandemics.Our “Research” page contains more information on our ongoing studies.